Purchase the book Right to Recover

Right to Recover ~ Winning the Political and Religious Wars Over Stem Cell Research in America presents scientific facts that challenge readers to think for themselves rather than accept political or religious views on stem cell research.


This book is available by request in bookstores nationwide.

RIGHT TO RECOVER is an Award-Winning Finalist in the Current Events: Political/Social of the National Best Books 2007 Awards. Amazon Best-selling book in biomedical category.

Monday, June 29, 2009

Editorial: Promising news on stem cell research

Here is some good news amid the general gloom: Scientists at the Salk Institute in La Jolla say they have cured a cell.

In a paper in the journal Nature, the Salk team reports it has fixed a defective gene in cells taken from patients with Fanconi anemia, a disease that can cause bone-marrow failure, leukemia and other cancers.

Read more here.. http://tinyurl.com/o8effx

Friday, June 26, 2009

Stem-Cell Guidelines Are a Good Start

The storm raised by stem-cell scientists about the failure of the National Institutes of Health draft guidelines to grandfather in stem-cell lines already in use is overshadowing other important issues raised by these guidelines ["New Rules on Stem Cells Threaten Current Research," news story, May 25].

The guidelines admirably add certain protections for those who make the difficult decision to donate, for stem-cell research, embryos remaining after in vitro fertilization treatment. Such protections did not appear in the Bush-era guidelines. While the protections complicate the informed-consent process, the grandfathering issue they raise can be remedied by adopting sections of the National Academy of Sciences guidelines addressing it.

Read more here.. http://tinyurl.com/qmrgzv

Tuesday, June 23, 2009

Saving Cord Blood

I have four grandbabies coming this year. One is already here and the next one is due today. I hope they never have to use it, but I have encouraged each of my daughters to save their baby’s cord blood.

I believe there are cures to be found in stem cells—the younger the cells, the more potential they have. In fact, I know that people have been helped and even cured of many illnesses using placental stem cells at a clinic in Mexico.

Read more here.. http://tinyurl.com/m5gznu

Saturday, June 20, 2009

Embryonic Stem Cell Research for Amyotrophic Lateral Sclerosis (ALS)

ALS is often called Lou Gehrig's disease, but the face of ALS today is Stephen Hawking. He's the wheelchair-bound British astrophysicist who has lived with the crippling disease for almost 50 years.

He got married, had children, and rose to international fame as a professor at Cambridge after his diagnosis. His web site, http://hawking.org.uk, chronicles the life of this remarkable man. My favorite part is the photo: he can still smile.

Read more here.. http://tinyurl.com/kwmajb

Wednesday, June 17, 2009

Another Attack on California Stem Cell Research Program?

Action Requested: share this information with friends. Consider sending polite letter of support for the California stem cell program to: littlehoover@lhc.ca.gov, attention Stuart Drown. Watch www.stemcellbattles.com for a potential new law attacking the California Institute for Regenerative Medicine.

Dear Stem Cell Research Supporter:

On May 27th, an open meeting of the Little Hoover Commission was held to discuss ways to drastically overhaul the California stem cell program.

It was a disaster.

First, a little background. The Little Hoover Commission* (LHC) is a California "efficiency organization" with the power to suggest new laws to "improve" the function of California programs. That sounds okay, doesn’t it?

But the California stem cell program has already been "improved" half to death; much more such "improvement" and the patient may not survive!

As you know, the CIRM (California Institute of Regenerative Medicine) has endured three lawsuits, (which nearly shut it down for two years); been audited five times (came up squeaky clean, thank you very much), and has had seven (7) laws thrown at it; can anyone name a government program which has been more systematically investigated, almost to the point of harassment?

And yet it has prevailed. All seven laws were defeated, the audits found the CIRM open and honest, the lawsuits were defeated on every point.

But now comes the Little Hoover Commission anyway, to take its turn.

Friends of this column might remember I have been worried about this group.

As you know, stem cell research’s greatest enemy in California is probably Senator George Runner. Mr. Runner, described by one newspaper (the Los Angeles City Beat, 3/24/05) as "virulently anti-embryonic stem cell Republican George Runner" is against our research in general and Proposition 71 in particular. He is, I believe, co-author to every anti-CIRM law that has been proposed. One of his bills was the source of the original request for the Little Hoover Commission to study the California program, and his wife, Assemblywoman Sharon Runner, was until very recently a member of the Little Hoover Commission.

However, at the first meeting of the LHC discussing the stem cell program, several board members complimented it. One said Bob Klein deserved "an A plus" for leveraging $272 million in California dollars into $1.15 billion in purchasing power; another said the program should be studied as an example of government at its best: successful public/private partnership.

So was I worried for nothing?

Unfortunately, no. My worst fears were just realized.

Here are three of the LHC’s proposed changes. (They said a lot more, but they were talking very fast, and I am only a two-finger typist—not to mention they provided zero written documents as to their recommendations, which made things rough on people trying to provide accurate coverage of the public meeting.)

1. The Little Hoover Committee would gut the leadership board of the California stem cell program, the Independent Citizens Oversight Committee (ICOC): weakening it, and putting it under political control. They would reduce the ICOC by half, from 29 to 15 members. And, in place of the non-political structure of the board, the LHC would impose a new way to select the membership, politicizing it.

The ICOC is a non-political governing board, designed to be above ideology and partisan politics.

It is deliberately large, 29 members, so as to provide a diverse cross-section of opinion: science, education, business, patient advocates.

The LHC was quite open about their intention: they wanted to impose a "more traditional board where the Governor and Legislation have control". This not only opens up the possibility of removing our funding, but flouts the voters’ will; California voted for a program where science would be judged on its own merits, not subject to the changing winds of political ideology.

2. The Little Hoover Commission would take away the ICOC board Chairman’s salary, as well as the vice-Chair’s. They would deliberately weaken the Chair’s authority by transferring most of his responsibilities to the President. Also, they would shorten his term in office from 6 years to two; there was even talk of eliminating his position altogether, or passing it around the ICOC membership, taking turns, making the position a "non-executive executive"!

This is ludicrous.

To understand what a mistake this would be, consider what skills the chairperson must provide, both by need, and by California law.

First, how is our program funded? Our only source of money is the sale of California bonds. No bond sales, no funding. Fortunately, our current Chairperson, Robert N. Klein II is an acknowledged expert on these bonds, having worked with them since 1975. (Klein set up and helped run the highly successful California Housing Finance Agency, also financed by bonds.)

Second, the success of our program depends on deep knowledge of and experience in interaction with state and federal law.

The chair is Bob Klein, the man who designed the California stem cell program, and who has steered it through innumerable crises. He served unpaid for the first five years, before financial conditions forced him to take a salary, $150,000 a year, small compared to most executives.

Could he be replaced by a board member or even the President of CIRM?

Under the law, "Mandatory Chairperson Criteria" Proposition 71 requires:

"...(ii) Experience with state and federal legislative processes that must include some experience with medical legislative approvals of standards and/or funding."

It also suggests: "(B) Additional criteria for Consideration:...

(iv) Direct knowledge of and experience in bond financing."

Do we know anybody like that? Hmm, let’s see. The President, esteemed scientist Dr. Alan Trounson, (being Australian) would not be eligible under the law, because he has no such experience; also according to his testimony, he has no understanding of bond sales, which are the lifeblood of our program.

Who does know about bond sales, and whose idea was it to use them to fund the stem cell program? Bob Klein.

Whose idea was it to develop and sell "bridge anticipation notes"—BANs, another form of bond—which got us through the first two years when law suits blocked our funding? Bob Klein.

And who is trying right now to negotiate federal guarantees for our loans to biomed companies—as much as a billion dollars backup funding? Bob Klein.

One false step, and we could lose millions of dollars of new money for California.

We must have a chair who understands not only the twists and turns of stem cell politics, but also the complications of bond finance.

To the best of my knowledge, there is exactly one person in the world with a skill set like that—
the man the Little Hoover Commission would "term out" of office.

3. The LHC proposes hiring more staff to help with the work at CIRM. That sounds pretty good, at first—except they would not authorize any more money for this. Prop 71, by law, can only spend 6% of total funding on employees. The LHC noted that, but suggests no provision to change it. Apparently they expect current employees to take a pay cut to hire the new workers.

So, if we cut everyone’s salary in half, we could hire twice as many people! An interesting concept. I wonder which of the LHC members would like to go first, and reduce his or her income, by way of example? Throughout the hearing, LHC board members displayed a staggering lack of knowledge about the program they would so radically change.

Example: as a reason to change the ICOC governing board, one LHC member stated that biotech was "locked out of representation on the (ICOC) board"...apparently not realizing four biotech representatives are in fact installed on that board.

Example: Objections were raised to the alleged "throwing out" of the CIRM’s strategic plan. CIRM spokesperson Don Gibbons pointed out that this was incorrect: the "new" strategic plan was an addition to and extension of the previous one, not a replacement: and this fact was plainly labeled as such, from the front page onward. These additions included the new loan program, and also reflected some major changes in science.

Example: One member came close to slandering the men and women of the ICOC, accusing them of "giving themselves grants... anyone would want to play cards, if they could be guaranteed a stacked deck." This is not only insulting, but factually inaccurate; board members are not even allowed to speak about grants affecting their institutions, let alone vote on "giving themselves grants".

The public was not allowed to view the LHC draft document.

True. The board members and staff were allowed to have copies of the proposed changes, but not the public. This would seem contradictory to the LHC’s mission of increasing transparency of government. Apparently, the only time the public will see the actual document-- will be after it is too late to offer comments on it!

Important: LHC members stated several times that they were against any legislative changes which would require "going to the people", i.e. needing a public vote. They much preferred a legislature-only approach. The people, one individual noted, are "not interested in change".

Others agreed, calling it (popular vote on change) "arduous" and "futile". At an earlier meeting of the LHC, a member stated his opinion that at least some of the changes sought by critics could not be achieved without a Constitutional amendment, which means a public vote.

Prop 71 was passed by initiative, and approved by the voters of California; much of the law was placed in the Constitution, meaning a vote of the public would almost certainly be required to amend it.

So would the LHC changes be Constitutionally legal?

"That’s for the courts to decide," one member said, shrugging off the possibility of a few more years in court.

As the father of a paralyzed young man, I cannot be so casual about anything which may delay cure research. This struggle is personal to me, not some sort of intellectual exercise. The scientific challenges are difficult enough, without needless political delay.

When the meeting was over, a member of the LHC came up to me and said, "We want the CIRM to thrive and flourish!"

To which I responded, "Then why gut it? Why remove the heart and soul of a highly successful program?"

By any objective measure, the California stem cell program is an enormous success. Just one example: remember the $272 million budgeted for construction—which was leveraged into $1.15 billion in buying power. How did the ICOC and its Chairman accomplish this? They insisted that matching funds be required from institutions seeking facilities grants. In this manner the purchasing power of California dollars was multiplied three times over. How many programs, public or private, can bring in more funds than they put out? I know of none. And this is the Committee the LHC would weaken; this is the chairman whose salary the LHC would take away.

The ICOC board is a convergence of expertise, not a conflict of interest. Their diversity is a strength, and their chair makes sure every viewpoint is heard, which is probably why most decisions are close, often unanimous; they wrestle out their decisions, arguing, struggling, working it out, finding what is right—in the full light of public view-- and California benefits.

The old expression applies: "if it ain’t broke, don’t fix it."

Does that mean the program is perfect? Of course not. No institution on earth should be beyond correction. If a speed-reader was to wade through the endless pages of the public record of the ICOC meetings, he or she would find countless arguments about policy and performance, as problems are identified, dealt with, and policies set up to prevent their recurrence. That is healthy.

Positive interaction with our governmental leadership in Sacramento and Washington is actively sought; witness our new Vice-President, cancer-survivor Art Torres, whose sole job that is. Mr. Torres is a veteran of many years public service, including working with Cesar Chavez and the farm workers union, and he came out of retirement just to work with the California Institute for Regenerative Medicine.

Well, there it is.

The final draft of the Little Hoover Commission report will be released soon.

If you want to offer your thoughts and recommendations, or just voice your support for the California program, send an email to littlehoover@lhc.ca.gov, attention Stuart Drown. (On a personal note, I have met Mr. Drown several times, and corresponded with him, and he has always been polite and professional.)

So what do we do now? Consider writing the letter.

Above all, get ready.

Update your email lists. If you live in California, consider the idea of visiting Sacramento in the near future. If Senator Runner or someone else puts up a law based on LHC, which he almost certainly will, there will be hearings to attend.

If you don’t live in California, we will still need your help. This will be an interactive effort. If an attack law develops, we who support the CIRM will be going through our phonebooks and e-lists, organizing our defense.

Across America, wherever you live, the success or failure of the California stem cell program
affects you and your loved ones: all who hope and work for cure.

Let there be no doubt in anybody’s mind. We in the patient advocacy community appreciate, support, and will defend the CIRM and the ICOC. It is the concrete realization of our hopes for cure, an institution dedicated solely to finding cures for illness and injury which afflict our families-- we will not sit idly by when it is attacked.

Any law calling for a weakening or political "do-over" of California’s stem cell program must and will be vigorously opposed. Don C. Reed, co-chair, Californians for Cures Californians for Cures sponsored the Roman Reed Spinal Cord Injury Research Act, source of the first state-funded embryonic stem cell research in America.

*Important: Not all the LHC board members were present that day, (this is budget crisis time at the California capitol) and I know of at least one member who strongly opposes the direction the committee is taking. It may be that the committee will reconsider their current position-- a good reason to send them your thoughts: littlehoover@lhc.ca.gov.

Wednesday, June 10, 2009

Stem cell grant seals the deal

Unlike what you may have heard or read, stem cells are very unlikely to cause cancer. Right-wing groups used this lie to distract people from supporting embryonic stem cell research. The truth is that these stem cells may actually be the cure for cancer once they are fully understood.

Read more here.. http://tinyurl.com/r236wu

Sunday, June 7, 2009

Activated stem cells in damaged lungs could be first step toward cancer

DURHAM, N.C. – Stem cells that respond after a severe injury in the lungs of mice may be a source of rapidly dividing cells that lead to lung cancer, according to a team of American and British researchers.

"There are chemically resistant, local-tissue stem cells in the lung that only activate after severe injury," said Barry R. Stripp, Ph.D., professor of medicine and cell biology at Duke University Medical Center. "Cigarette smoke contains a host of toxic chemicals, and smoking is one factor that we anticipate would stimulate these stem cells. Our findings demonstrate that, with severe injury, the resulting repair response leads to large numbers of proliferating cells that are derived from these rare stem cells."

Read more here.. http://tinyurl.com/nbnoap

Thursday, June 4, 2009

Medical Council finalises stem cell regulation

The deadline for submitting comments to the National Institutes of Health (NIH) is over and the guidelines will soon be established to monitor federal funding for blastocystic (embryonic) stem cell research in the U.S.

The Medical Council of Thailand has completed a draft regulation on clinical trials using stem cell technology to provide consumers with better protection. Once it is submitted to the public health minister for approval, the guidelines will be published in the Royal Gazette.

Read more http://tinyurl.com/m2urob

Monday, June 1, 2009

Geron: Strong Investment in Human Embryonic Stem Cell Research

Geron is scheduled to begin the first ever human clinical trial with human embryonic stem cells (hESC) as the treatment this summer. The goal is to repair and regenerate the myelin sheath of spinal cord injuries. It is also using hESC to develop cardiomyocytes for heart disease which is in product development; islets for diabetes, chondrocytes for cartilage regeneration, osteoblasts for bone regeneration, and hepatocytes for liver disease.

Read more of Ryan Pollack’s article at http://tinyurl.com/mq9tjb